163 related articles for article (PubMed ID: 28882010)
61. Candidemia in children.
Zaoutis T
Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
[TBL] [Abstract][Full Text] [Related]
62. Pediatric invasive fungal infections: realities, challenges, concerns, myths and hopes.
Dinleyici EC
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):273-4. PubMed ID: 21417863
[No Abstract] [Full Text] [Related]
63. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
[TBL] [Abstract][Full Text] [Related]
64. Single-center retrospective study of the incidence of, and risk factors for, non-C. albicans invasive candidiasis in hospitalized patients in China.
Wang L; Tong Z; Wang Z; Xu L; Wu Y; Liu Y; Wu L
Med Mycol; 2014 Feb; 52(2):115-22. PubMed ID: 24626056
[TBL] [Abstract][Full Text] [Related]
65. [Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients].
Piemonte P; Conte G; Flores C; Barahona O; Araos D; Alfaro J; Fardella P; Thompson L
Rev Med Chil; 1996 Sep; 124(9):1149. PubMed ID: 9197032
[No Abstract] [Full Text] [Related]
66. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
Böhme A; Karthaus M; Hoelzer D
Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
[TBL] [Abstract][Full Text] [Related]
67. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies.
Myoken Y; Kyo T; Fujihara M; Sugata T; Mikami Y
Haematologica; 2004 Mar; 89(3):378-80. PubMed ID: 15020289
[TBL] [Abstract][Full Text] [Related]
68. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
[TBL] [Abstract][Full Text] [Related]
69. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals.
Nucci M; Colombo AL
Diagn Microbiol Infect Dis; 2007 May; 58(1):77-82. PubMed ID: 17368800
[TBL] [Abstract][Full Text] [Related]
70. Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
Tapısız A
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):339-46. PubMed ID: 21417873
[TBL] [Abstract][Full Text] [Related]
71. Breakthrough candidemia in children: clinical and microbiological characteristics, therapeutic strategies and impact on outcomes.
Lai MY; Hsu JF; Chu SM; Wu IH; Huang HR; Lin CC; Lee IT; Chiang MC; Fu RH; Tsai MH
Future Microbiol; 2017 Jun; 12():695-705. PubMed ID: 28326813
[TBL] [Abstract][Full Text] [Related]
72. Current treatment strategies for disseminated candidiasis.
Spellberg BJ; Filler SG; Edwards JE
Clin Infect Dis; 2006 Jan; 42(2):244-51. PubMed ID: 16355336
[TBL] [Abstract][Full Text] [Related]
73. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Martin-Loeches I; Antonelli M; Cuenca-Estrella M; Dimopoulos G; Einav S; De Waele JJ; Garnacho-Montero J; Kanj SS; Machado FR; Montravers P; Sakr Y; Sanguinetti M; Timsit JF; Bassetti M
Intensive Care Med; 2019 Jun; 45(6):789-805. PubMed ID: 30911804
[TBL] [Abstract][Full Text] [Related]
74. Approaches to the early treatment of invasive fungal infection.
Ito JI; Kriengkauykiat J; Dadwal SS; Arfons LM; Lazarus HM
Leuk Lymphoma; 2010 Sep; 51(9):1623-31. PubMed ID: 20629521
[TBL] [Abstract][Full Text] [Related]
75. Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?
Georgiadou SP; Tarrand J; Sipsas NV; Kontoyiannis DP
Mycoses; 2013 May; 56(3):311-4. PubMed ID: 23170870
[TBL] [Abstract][Full Text] [Related]
76. Pharmacokinetics of anidulafungin during albumin dialysis.
Aguilar G; Azanza JR; Sádaba B; Badenes R; Ferrando C; Delgado C; Hernández J; Parra MA; Puig J; Carbonell JA; Navarro D; Belda FJ
Crit Care; 2014 Mar; 18(2):422. PubMed ID: 25028805
[No Abstract] [Full Text] [Related]
77. Update on management of invasive candidiasis.
Candel FJ; Pazos Pacheco C; Ruiz-Camps I; Maseda E; Sánchez-Benito MR; Montero A; Puig M; Gilsanz F; Aguilar J; Matesanz M
Rev Esp Quimioter; 2017 Dec; 30(6):397-406. PubMed ID: 29115366
[TBL] [Abstract][Full Text] [Related]
78. Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.
Colombo AL; Agnelli C; Kontoyiannis DP
J Antimicrob Chemother; 2021 Feb; 76(3):543-546. PubMed ID: 33150364
[TBL] [Abstract][Full Text] [Related]
79. Oropharyngeal Candida colonization and infection in neutropenic patients with hematologic malignancies.
Myoken Y; Sugata T; Fujita Y; Kohara T; Mikami Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):137-8; author reply 138. PubMed ID: 14989288
[No Abstract] [Full Text] [Related]
80. Biomarkers in early treatment of invasive candidiasis.
Rouze A; Poissy J; Sendid B; Nseir S
Hosp Pract (1995); 2018 Dec; 46(5):239-242. PubMed ID: 30139287
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
